0 CHECKOUT

Nanoparticle Drug Delivery Market & Clinical Pipeline Insight

  • ID: 2865444
  • June 2014
  • Region: Global
  • 475 Pages
  • Kuick Research
Special Offer Banner
10%
OFF
Offer ends 10th Jul 2016
1 of 4

FEATURED COMPANIES

  • Abraxis BioScience,
  • Access Pharmaceuticals,
  • Alnylam Pharmaceuticals,
  • Arrowhead Research,
  • BIND Biosciences,
  • iCeutica,
  • MORE

Drug delivery technologies currently occupy a significant position in the pharmaceutical industry. It has become so important that the mode of delivery of drugs has come to define the efficiency and marketability of those drugs. The pharmaceutical industry is witnessing a shift in the focus of the stakeholders towards newer systems of drug delivery in order to achieve efficient and safe transportation of novel products and formulations. There have been many products which have been derived from new delivery systems and are currently attracting the attention of different companies. It has been recognized that the introduction of a new drug delivery system would bring along a potential chance for an existing drug candidate molecule.

The field of nanotechnology is considered to be an exciting area which offers the potential for developing drug delivery systems using nanoparticles, with dimension range of 1-100 nm. These nanoparticles tend to have the ability to deliver an adequate range of molecules to different areas of the body. Additionally, these nanoparticles also posses the capability to deliver the molecules for a comparatively longer duration of time as compared to other READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abraxis BioScience,
  • Access Pharmaceuticals,
  • Alnylam Pharmaceuticals,
  • Arrowhead Research,
  • BIND Biosciences,
  • iCeutica,
  • MORE

1. Introduction to Nanoparticle Technology for Drug Delivery

2. Nanoparticle Drug Delivery Mechanism
2.1 Protein Based Delivery Systems
2.2 Natural Polymers & Derivates
2.3 Polymeric Carriers
2.4 Dendrimers
2.5 Fullerene
2.6 Carbon Nanotubes

3. Application of Nanotechnology for Drug Delivery

4. Nanoparticle Drug Delivery Market Overview
4.1 Market Overview
4.2 Clinical Insight

5. Nanoparticle Drug Delivery Market Dynamics
5.1 Drivers
5.2 Challenges
5.3 Future Outlook

6. Nanoparticle Drug Delivery Clinical Pipeline by Phase, Country & Indication
6.1 Research
6.2 Preclinical
6.3 Phase I
6.4 Phase I/II
6.5 Phase II
6.6 Phase II/III
6.7 Phase III

7. Marketed Nanoparticle Drug

8. Suspended & Discontinued Nanoparticle Drug Profiles
8.1 No Development Reported
8.2 Discontinued
8.3 Suspended

9. Competitive Landscape
9.1 Abraxis BioScience
9.2 Access Pharmaceuticals
9.3 Alnylam Pharmaceuticals
9.4 Arrowhead Research
9.5 BIND Biosciences
9.6 iCeutica
9.7 NanoCarrier
9.8 Nippon Kayaku
9.9 Nanobiotix
9.10 Samyang

List Of figures:

Figure 1-1: Nanoparticle Technology for Drug Delivery
Figure 1-2: Nanoparticle Class
Figure 2-1: Nanoparticle Drug Delivery System
Figure 4-1: Nanoparticle Drug Delivery Market (US$ Billion), 2013-2020
Figure 4-2: Nanoparticle Drugs in Clinical Pipeline by Phase (%)
Figure 4-3: Number Nanoparticle Drugs in Clinical Pipeline by Phase (%)
Figure 4-4: No Development in Nanoparticle Drugs in Clinical Pipeline by Phase (%)
Figure 4-5: Number of No Development in Nanoparticle Drugs in Clinical Pipeline by Phase
Figure 4-6: Discontinued Nanoparticle Drugs in Clinical Pipeline by Phase (%)
Figure 4-7: Number of Discontinued Nanoparticle Drugs in Clinical Pipeline by Phase
Figure 4-8: Suspended Nanoparticle Drugs in Clinical Pipeline by Phase (%)
Figure 4-9: Number of Suspended Nanoparticle Drugs in Clinical Pipeline by Phase
Figure 9-1: Arrowhead Research Corporation Clinical Pipeline
Figure 9-2: NanoCarrier Clinical Pipeline

Note: Product cover images may vary from those shown
3 of 4

- Abraxis BioScience,
- Access Pharmaceuticals,
- Alnylam Pharmaceuticals,
- Arrowhead Research,
- BIND Biosciences,
- NanoCarrier,
- Nanobiotix,
- Nippon Kayaku,
- Samyang
- iCeutica,

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be shipped to you in CD ROM format.

  • Quick Help: A printed copy of the report will be shipped to you.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • FEI Company
  • General Electric (GE) Company
  • Stora Enso Oyj
  • Evonik Industries AG
  • Saint-Gobain S.A.
  • STMicroelectronics